These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7751527)

  • 41. Nasal disorders and anticholinergic therapy.
    Borum P
    Postgrad Med J; 1987; 63 Suppl 1():61-8. PubMed ID: 2962076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea.
    Borum S; Becker B; Mygind N; Borum P
    Rhinology; 1996 Dec; 34(4):198-200. PubMed ID: 9050095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symposium: The upper airways under attack.
    Eur J Respir Dis Suppl; 1983; 126():113-48. PubMed ID: 6233168
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ipratropium bromide nasal spray for treatment of rhinorrhea in the laryngectomized patient: a pilot study.
    Magardino TM; Suskind-Liu D; Kroger H; Mirza N
    Am J Rhinol; 2001; 15(3):203-6. PubMed ID: 11453509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ordinary and high-dose ipratropium in perennial nonallergic rhinitis.
    Kirkegaard J; Mygind N; Mølgaard F; Grahne B; Holopainen E; Malmberg H; Brøondbo K; Røjne T
    J Allergy Clin Immunol; 1987 Apr; 79(4):585-90. PubMed ID: 2951426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nasal methacholine challenge and ipratropium therapy. Laboratory studies and a clinical trial in perennial rhinitis.
    Borum P; Mygind N
    Acta Otorhinolaryngol Belg; 1979; 33(4):528-35. PubMed ID: 161465
    [No Abstract]   [Full Text] [Related]  

  • 50. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis.
    Howland WC; Dockhorn R; Gillman S; Gross GN; Hille D; Simpson B; Furst JA; Feiss G; Smith JA
    J Allergy Clin Immunol; 1996 Jul; 98(1):32-8. PubMed ID: 8765815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes of T-helper type 1/2 cell balance by anticholinergic treatment in allergic mice.
    Daoud A; Xie Z; Ma Y; Wang T; Tan G
    Ann Allergy Asthma Immunol; 2014 Mar; 112(3):249-55. PubMed ID: 24428969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.
    Strandell B; Norgren-Holst E; Tran N; Jakobsen HB; Chen S
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):744-51. PubMed ID: 19954713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absorption across the nasal airway mucosa in house dust mite perennial allergic rhinitis.
    Greiff L; Andersson M; Svensson J; Wollmer P; Lundin S; Persson CG
    Clin Physiol Funct Imaging; 2002 Jan; 22(1):55-7. PubMed ID: 12003101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal ipratropium: literature abstracts and comments.
    Mygind N; Borum P
    Rhinol Suppl; 1989; 9():37-44. PubMed ID: 2534054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy.
    Garrelds IM; van Amsterdam JG; de Graaf-in't Veld C; Gerth van Wijk R; Zijlstra FJ
    Thorax; 1995 Mar; 50(3):275-9. PubMed ID: 7660342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold.
    Graf P; Eccles R; Chen S
    Expert Opin Pharmacother; 2009 Apr; 10(5):889-908. PubMed ID: 19351236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficiency of a New Mesh-Type Nebulizer (NE-SM1 NEPLUS) for Intrapulmonary Delivery of Ipratropium Bromide in Surgical Patients.
    Lee YH; Kwon GY; Park DY; Bang JY; Jang DM; Lee SH; Lee EK; Choi BM; Noh GJ
    Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):313-9. PubMed ID: 26440415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.